0000914760-16-000498.txt : 20161201 0000914760-16-000498.hdr.sgml : 20161201 20161201172703 ACCESSION NUMBER: 0000914760-16-000498 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161201 DATE AS OF CHANGE: 20161201 EFFECTIVENESS DATE: 20161201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurovance, Inc. CENTRAL INDEX KEY: 0001544176 IRS NUMBER: 454090332 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-258396 FILM NUMBER: 162029195 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET STREET 2: SUITE S1-3 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-758-0300 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET STREET 2: SUITE S1-3 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D/A 1 primary_doc.xml X0707 D/A LIVE 0001544176 Neurovance, Inc. 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA MASSACHUSETTS 02141 617-758-0300 DELAWARE None None Corporation true 2011 Jeffrey Bailey 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Executive Chairman Anthony A. McKinney 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Chief Development Officer Campbell Murray Novartis Venture Fund 355 Main Street, Suite 603 Cambridge MA MASSACHUSETTS 02142 Director Daniel Omstead Tekla Healthcare/Tekla Life Sciences Inv 2 Liberty Square, 9th Floor Boston MA MASSACHUSETTS 02109 Director Brigitte Smith GBS Venture Partners Limited Level 5, 71 Collins Street Melbourne VIC C3 AUSTRALIA 3000 Director Paul Weiss Venture Investors Early Stage Fund IV 505 South Rosa Road, Suite 201 Madison WI WISCONSIN 53719 Director Timothy J. Barberich 48 Elm Street Concord MA MASSACHUSETTS 01742 Director William T. Pappafotopoulos 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Vice President, Finance and Administration Gregg Beloff 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Acting Chief Financial Officer Albert L. Sokol 28 State Street Boston MA MASSACHUSETTS 02109 Executive Officer Secretary Biotechnology No Revenues 06b true 0000908662-16-000489 2016-02-24 false true true false 0 16000000 7500000 8500000 false 7 0 0 0 true Other than the payment of salaries and other compensation and benefits in the ordinary course, no persons required to be named as executive officers, directors or promoters in response to Item 3 will receive any payment from the proceeds of this offering. false Neurovance, Inc. /s/ Albert L. Sokol Albert L. Sokol Secretary 2016-12-01